Alcon Inc
ALC: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$38.00 | Wtbbdwy | Vvhpdpkw |
Alcon Among Leaders in Contact Lens Market and Dominant in Ophthalmic Surgical Space
Business Strategy and Outlook
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical.